Pharmacologic Treatment of Portal Hypertension.
Clin Liver Dis
; 28(3): 417-435, 2024 Aug.
Article
de En
| MEDLINE
| ID: mdl-38945635
ABSTRACT
Portal hypertension is the key mechanism driving the transition from compensated to decompensated cirrhosis. In this review, the authors described the pathophysiology of portal hypertension in cirrhosis and the rationale of pharmacologic treatment of portal hypertension. We discussed both etiologic and nonetiologic treatment of portal hypertension and the specific clinical scenarios how nonselective beta-blocker can be used in patients with cirrhosis. Finally, the authors summarized the evidence for emerging alternatives for portal hypertension in patients with cirrhosis.
Mots clés
Texte intégral:
1
Collection:
01-internacional
Base de données:
MEDLINE
Sujet principal:
Antagonistes bêta-adrénergiques
/
Hypertension portale
/
Cirrhose du foie
Limites:
Humans
Langue:
En
Journal:
Clin Liver Dis
Sujet du journal:
GASTROENTEROLOGIA
Année:
2024
Type de document:
Article
Pays d'affiliation:
Canada
Pays de publication:
États-Unis d'Amérique